An advocacy group has issued a “call to arms” to make sure patients are closely consulted in the development of digital health technologies. The steering committee of the European Patient Innovation Summit (EPIS). A Novartis-backed group set up in 2016 as a platform for patient advocates to discuss digital health. Stated that the call aims
Pharmaceutical companies are making more of an effort to engage with European patients through digital challenges, but their success in doing so can vary as a small handful of innovators starts to emerge. Decision Resources Group (DRG) identified Novartis, Pfizer and Sanofi as best-in-class when it came to the range and sophistication of the digital
Novartis has signalled its intention to change the way it approaches and uses technology, creating a new Chief Digital Officer role and filling it with a former retail executive. The tactic last month was hot on the heels of GSK’s decision to pick former Walmart Chief Information Officer, Karenann Terrell, to be its Chief Digital
Novartis has launched the first large-scale research study in multiple sclerosis using Apple’s ResearchKit software. Participants in the trial will have the ability to contribute directly from their smartphones, via sensors that will collect movement and symptom data, removing the need for clinic visits. The US mobile-enabled study uses a free-to-download iPhone app that was
Novartis UK has recently joined Twitter, becoming the latest pharmaceutical firm set up a twitter account in the country, where a cautious approach appears to be the norm for the industry. From their outlined Twitter guidelines, Novartis plans a 48-hour turnaround for responding to direct messages and requests users not to turn to the network
When pharma giant Novartis first started marketing Entresto, a heart failure drug, it found itself facing criticism from cardiologists and consumers who found the direct-to-consumer ads too negative. In light of the criticism, Novartis has now taken a different approach to promoting the heart failure drug. In partnership with the American Heart Association and actress/singer
